PHS2 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Components: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
PHS2 antibody; At3g46970 antibody; F13I12.20 antibody; Alpha-glucan phosphorylase 2 antibody; cytosolic antibody; AtPHS2 antibody; EC 2.4.1.1 antibody; Alpha-glucan phosphorylase antibody; H isozyme antibody; Starch phosphorylase H antibody
Target Names
PHS2
Uniprot No.

Target Background

Function

Phosphorylase is a crucial allosteric enzyme in carbohydrate metabolism. While enzymes from different sources exhibit variations in their regulatory mechanisms and natural substrates, all known phosphorylases share common catalytic and structural properties.

Gene References Into Functions

PHS2 activity plays a significant role in adult organisms under low-light conditions and during senescence. It is also important during extended seedling development when carbohydrate homeostasis is disrupted. (PMID: 24888726)

Database Links

KEGG: ath:AT3G46970

STRING: 3702.AT3G46970.1

UniGene: At.879

Protein Families
Glycogen phosphorylase family
Subcellular Location
Cytoplasm.

Q&A

What is PHS2 protein and why is it significant in plant biology research?

PHS2 (also identified as Q9SD76 in UniProt database) is a protein primarily studied in the model organism Arabidopsis thaliana (Mouse-ear cress) . It belongs to a family of proteins involved in plant metabolic processes. The significance of PHS2 lies in its role in plant development and stress responses, making it an important target for researchers investigating fundamental plant biology mechanisms.

Antibodies against PHS2 enable researchers to track protein expression, localization, and interactions in various experimental contexts. The availability of commercial antibodies specifically targeting PHS2 in Arabidopsis thaliana indicates its research significance in plant molecular biology . When designing experiments with PHS2 antibodies, researchers should consider both tissue-specific expression patterns and potential cross-reactivity with related proteins.

What validation methods should I use to confirm PHS2 antibody specificity?

Antibody validation is critical for ensuring experimental reliability. For PHS2 antibody, validation should include:

  • Western blot analysis: Compare wild-type Arabidopsis samples with PHS2 knockdown/knockout lines to confirm the absence of target band in mutant plants.

  • Immunoprecipitation followed by mass spectrometry: This approach can confirm that the antibody is capturing the intended protein rather than cross-reactive species.

  • Pre-adsorption controls: Pre-incubate the antibody with purified PHS2 protein before immunostaining to confirm signal specificity.

  • Cross-reactivity assessment: Test against related plant species to determine species specificity, as antibody cross-reactivity can provide both challenges and opportunities in experimental design .

When reporting validation results, include detailed methods and positive/negative controls to allow other researchers to properly interpret your findings.

How should I optimize sample preparation for PHS2 detection in plant tissues?

Sample preparation is crucial for successful antibody-based detection of PHS2 in plant tissues. The optimal protocol involves:

  • Tissue selection: Choose appropriate tissue types based on known expression patterns of PHS2 in Arabidopsis thaliana.

  • Extraction buffer optimization: Use buffers containing:

    • 50 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • 1% Triton X-100

    • 0.5% sodium deoxycholate

    • Protease inhibitor cocktail

  • Membrane protein considerations: Since many antibodies target conformational epitopes, proper membrane protein extraction is essential for maintaining protein structure . Harsh detergents may disrupt conformational epitopes, as observed in studies of M2 protein antibodies, where conformation-dependent antibodies failed to recognize denatured forms .

  • Fixation parameters: For immunohistochemistry, use 4% paraformaldehyde fixation for 15-20 minutes to preserve epitope accessibility while maintaining tissue architecture.

Remember that sample preparation methods should be optimized and validated specifically for PHS2 detection, as protocols optimal for other proteins may not yield the best results for PHS2.

What are the optimal conditions for Western blotting using PHS2 antibodies?

For optimal Western blotting results with PHS2 antibody, follow these methodology-focused recommendations:

  • Protein extraction: Extract total protein from Arabidopsis tissue using a buffer containing phosphatase inhibitors to preserve any post-translational modifications that might affect antibody recognition.

  • Gel preparation: Use 10-12% SDS-PAGE gels for optimal resolution of PHS2 protein.

  • Transfer conditions:

    • Semi-dry transfer: 15V for 30 minutes

    • Wet transfer: 30V overnight at 4°C to ensure complete transfer of membrane-associated proteins

  • Blocking procedure: 5% non-fat dry milk in TBST (Tris-buffered saline with 0.1% Tween-20) for 1 hour at room temperature.

  • Antibody dilution: Typically 1:1000 to 1:2000 for primary antibody incubation, though this should be optimized for each specific antibody lot .

  • Detection system: HRP-conjugated secondary antibodies with ECL detection provide good sensitivity while maintaining low background for plant proteins like PHS2.

Similar to findings with M2 antibodies in influenza research, detection of native conformation may require different conditions than denatured proteins, so consider native gel electrophoresis if standard methods fail .

How can PHS2 antibodies be effectively used in immunoprecipitation studies?

For successful immunoprecipitation (IP) of PHS2 and associated proteins:

  • Antibody binding conditions:

    • Use 2-5 μg of purified PHS2 antibody per 500 μg of protein lysate

    • Incubate overnight at 4°C with gentle rotation

  • Bead selection:

    • Protein A/G beads work well for most mammalian antibodies

    • For plant-specific antibodies, test both Protein A and Protein G for optimal binding

  • Washing protocol:

    • Initial washes: 3 times with IP buffer containing 0.1% detergent

    • Stringent washes: 2 times with high-salt buffer (300 mM NaCl)

    • Final wash: 1 time with detergent-free buffer

  • Elution methods:

    Elution MethodAdvantagesDisadvantages
    Low pH (glycine, pH 2.5)Efficient elutionMay denature proteins
    SDS sample bufferComplete elutionIncompatible with some downstream applications
    Peptide competitionPreserves protein functionRequires synthesized epitope peptide
  • Verification steps: Confirm successful IP using Western blotting with a separate PHS2 antibody recognizing a different epitope to avoid detection of the IP antibody.

The M2-flow cytometric assay approach described for influenza virus research demonstrates how conformational antibodies can be used effectively when traditional methods present technical difficulties , suggesting similar approaches may benefit PHS2 research.

What controls are essential when using PHS2 antibodies in immunohistochemistry?

Proper controls are critical for accurate interpretation of immunohistochemistry results:

  • Positive tissue control: Include samples known to express PHS2 (e.g., specific Arabidopsis tissues with confirmed expression).

  • Negative tissue control: Include samples known not to express PHS2 or use PHS2 knockout plant material.

  • Primary antibody controls:

    • Omission control: No primary antibody to assess secondary antibody specificity

    • Isotype control: Irrelevant primary antibody of same isotype and concentration

    • Pre-absorption control: Primary antibody pre-incubated with purified PHS2 protein

  • Signal amplification controls: When using signal amplification systems, include controls without amplification to assess background.

  • Cross-reactivity assessment: Similar to studies on cross-reactive antibodies between HLA-B27 and pHS-2 sequences , test for potential cross-reactivity with homologous plant proteins.

How do I interpret contradictory results when using different PHS2 antibodies?

When facing contradictory results with different PHS2 antibodies:

  • Epitope mapping analysis: Determine which protein regions each antibody targets. Different antibodies may recognize distinct epitopes that are differentially accessible depending on protein conformation, post-translational modifications, or protein-protein interactions.

  • Antibody characterization comparison:

    • Polyclonal vs. monoclonal differences

    • Recognition of denatured vs. native conformations

    • Species cross-reactivity profiles

  • Experimental condition variations: Systematically alter key parameters (fixation methods, buffer compositions, incubation times) to determine if discrepancies are methodology-dependent.

  • Complementary technique validation: Use non-antibody-based methods (RT-PCR, mass spectrometry) to resolve conflicts, particularly when antibody specificity is uncertain.

Research on influenza virus M2 protein antibodies demonstrated that recognition of native conformation versus peptide epitopes can differ significantly, with the majority of antibodies in one study being conformational rather than linear epitope-specific . This finding suggests that similar considerations may apply to PHS2 antibodies.

What approaches help distinguish between specific signal and background when quantifying PHS2 expression?

For accurate quantification while minimizing background interference:

  • Threshold determination methodology:

    • Use statistical approaches like signal-to-noise ratio analysis

    • Employ multiple threshold values and compare outcomes

    • Consider Receiver Operating Characteristic (ROC) curve analysis

  • Background reduction strategies:

    • Optimize blocking conditions (concentration, time, blocking agent)

    • Include detergents at appropriate concentrations

    • Use reference tissues for normalization

  • Quantification methodology standardization:

    • Normalize using internal housekeeping proteins

    • Employ standard curves with recombinant PHS2 protein

    • Use digital image analysis with defined parameters

How should I address cross-reactivity issues with PHS2 antibodies?

Cross-reactivity management requires systematic approaches:

  • Pre-absorption studies: Incubate antibodies with potential cross-reactive proteins before use in experiments to reduce non-specific binding.

  • Knockout/knockdown validation: Compare signal in wild-type versus PHS2-deficient samples to confirm specificity.

  • Peptide competition assays: Determine if specific peptides can block antibody binding.

  • Cross-species analysis: Test antibody against related proteins from different species to map cross-reactivity patterns.

The concept of molecular mimicry, as demonstrated in studies where Shigella flexneri pHS-2 peptide more efficiently mimicked HLA-B27 peptide than did nitrogenase peptide , illustrates how structural similarity can drive cross-reactivity. This principle applies to potential cross-reactivity between PHS2 and related plant proteins.

How can PHS2 antibodies be integrated into multi-omics research approaches?

Integrating PHS2 antibodies into multi-omics research involves:

  • Proteomics integration:

    • Use PHS2 antibodies for immunoprecipitation followed by mass spectrometry

    • Combine with phosphoproteomics to identify post-translational modifications

    • Correlate protein expression with proteome-wide changes

  • Transcriptomics correlation:

    • Compare PHS2 protein levels (detected via antibodies) with transcript abundance

    • Investigate post-transcriptional regulation mechanisms

    • Identify discrepancies between protein and mRNA levels

  • Metabolomics connections:

    • Use PHS2 antibodies to study protein-metabolite interactions

    • Correlate PHS2 expression/localization with metabolic pathway outputs

    • Employ immunoprecipitation to isolate metabolite-binding complexes

  • Systems biology approaches:

    • Develop mathematical models incorporating antibody-derived PHS2 quantification

    • Use antibody data to validate predictions from computational models

    • Create integrated networks connecting protein dynamics to cellular outcomes

Similar to advanced approaches in influenza antibody research, where flow cytometric assays were developed to overcome technical limitations of traditional methods , innovative applications of PHS2 antibodies can drive new research directions.

What are the considerations for using PHS2 antibodies in studying protein-protein interactions?

For effective protein-protein interaction studies:

  • Co-immunoprecipitation optimization:

    • Preserve protein complexes with gentle lysis conditions

    • Cross-linking considerations (formaldehyde, DSP, etc.)

    • Salt and detergent concentrations that maintain interactions

  • Proximity ligation assay (PLA) applications:

    • Combine PHS2 antibody with antibodies against potential interacting partners

    • Optimize antibody dilutions to minimize background

    • Include appropriate controls for PLA signal specificity

  • FRET/FLIM microscopy integrations:

    • Label PHS2 antibodies with appropriate fluorophores

    • Consider steric hindrances in epitope access

    • Account for potential antibody-induced conformational changes

  • Native complex preservation strategies:

    • Blue native PAGE followed by Western blotting

    • Gradient gel techniques for complex size determination

    • Gentle elution methods that maintain complex integrity

Studies of viral protein antibodies have demonstrated that conformational epitopes can be critically important , suggesting careful attention to native structure preservation when studying PHS2 interactions.

How can I develop custom PHS2 antibodies for specialized research applications?

Developing specialized PHS2 antibodies requires:

  • Epitope selection strategy:

    • Target unique regions with high antigenicity

    • Avoid conserved domains if specificity is critical

    • Consider accessibility in native protein conformation

  • Immunization protocol design:

    • Select appropriate animal models (rabbits for polyclonal, mice for monoclonal)

    • Adjuvant selection based on epitope properties

    • Immunization schedule optimization

  • Screening methodology development:

    • ELISA against multiple protein forms (native, denatured)

    • Application-specific screening (IP, IHC, WB) during selection

    • Cross-reactivity elimination steps

  • Affinity purification approaches:

    • Epitope-specific purification columns

    • Negative selection against homologous proteins

    • Functional validation in application context

The successful development of sensitive and specific assays for antibody detection, as demonstrated in the M2-flow cytometric assay for influenza research , highlights the importance of innovative methodological approaches when traditional methods present limitations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.